[ad_1] AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash…
Tag: Autoimmune Diseases
This $5 Billion Biotech Home Run Took Less Than a Year
[ad_1] You can’t completely blame Pfizer’s executives, yet Roche’s $7 billion acquisition of a bowel-disease treatment that it owned until last year isn’t a great look. In a deal that…
He Was a Scientist. Could He Find a Drug to Treat His Own Disease?
[ad_1] How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” [ad_2] Source link